{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:51:40Z","timestamp":1762505500921},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:00:00Z","timestamp":1247184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11255-009-9611-4","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T10:03:27Z","timestamp":1247133807000},"page":"309-314","source":"Crossref","is-referenced-by-count":19,"title":["Patient awareness of smoking as a risk factor for bladder cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Ioannis","family":"Anastasiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios","family":"Mygdalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Mihalakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Adamakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Constantinides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionisios","family":"Mitropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,10]]},"reference":[{"key":"9611_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"9611_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"9611_CR3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","volume":"21","author":"MF Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R (2003) The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21(18):1315\u20131330","journal-title":"Pharmacoeconomics"},{"key":"9611_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0094-0143(21)01093-4","volume":"3","author":"AS Morrison","year":"1976","unstructured":"Morrison AS, Cole P (1976) Epidemiology of bladder cancer. Urol Clin North Am 3:13\u201329","journal-title":"Urol Clin North Am"},{"key":"9611_CR5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bjc.6690727","volume":"81","author":"FI Hsieh","year":"1999","unstructured":"Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ (1999) Genetic polymorphisms of N-acetyltransferase and 2 and risk of cigarette smoking related bladder cancer. Br J Cancer 81:537\u2013541","journal-title":"Br J Cancer"},{"key":"9611_CR6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1097-0142(197709)40:3<1246::AID-CNCR2820400340>3.0.CO;2-5","volume":"40","author":"EL Wynder","year":"1977","unstructured":"Wynder EL, Goldsmith K (1977) The epidemiology of bladder cancer. A second look. Cancer 40:1246\u20131268","journal-title":"Cancer"},{"key":"9611_CR7","volume-title":"Scientific foundations of urology","author":"I Thompson","year":"1990","unstructured":"Thompson I, Fair W (1990) Occupational and environmental factors in bladder cancer. In: Chisolm GD, Fair WR (eds) Scientific foundations of urology, 2nd edn. Heinemann Medical Books, London","edition":"2"},{"key":"9611_CR8","first-page":"536","volume":"23","author":"RK Ross","year":"1996","unstructured":"Ross RK, Jones PA, Yu MC (1996) Bladder cancer epidemiology and pathogenesis. Semin Oncol 23:536\u2013545","journal-title":"Semin Oncol"},{"key":"9611_CR9","first-page":"136","volume-title":"Chemical carcinogenesis and mutagenesis","author":"D Hoffmann","year":"1990","unstructured":"Hoffmann D, Hecht SS (1990) Advances in tobacco carcinogenesis. In: Cooper CS, Grover PL (eds) Chemical carcinogenesis and mutagenesis. Springer, Berlin, pp 136\u2013152"},{"issue":"8","key":"9611_CR10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0959-8049(05)80315-6","volume":"29A","author":"H Bartsch","year":"1993","unstructured":"Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P (1993) Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 29A(8):1199\u20131207","journal-title":"Eur J Cancer"},{"key":"9611_CR11","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6","volume":"86","author":"N Fleshner","year":"1999","unstructured":"Fleshner N, Garland J, Moadel A et al (1999) Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86:2337\u20132345","journal-title":"Cancer"},{"key":"9611_CR12","first-page":"86","volume":"15","author":"J Ostroff","year":"2000","unstructured":"Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L et al (2000) Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ 15:86\u201390","journal-title":"J Cancer Educ"},{"key":"9611_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1464-410X.1995.tb07748.x","volume":"76","author":"MP Raitanen","year":"1995","unstructured":"Raitanen MP, Nieminen P, Tammela TL (1995) Impact of tumor grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. Br J Urol 76:470\u2013474","journal-title":"Br J Urol"},{"key":"9611_CR14","unstructured":"US Department of Health and Human Service (1983) The health consequences of smoking: cardiovascular disease. A report of the surgeon general. US DHHS, Office of the Assistant Secretary of Health, Office on Smoking and Health, DHSS publication no. (PHS) 84-50204"},{"key":"9611_CR15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/ajrccm\/139.1.194","volume":"139","author":"DJ Tollerud","year":"1989","unstructured":"Tollerud DJ, Clark W, Brown LM et al (1989) Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Resp Dis 139:194\u2013198","journal-title":"Am Rev Resp Dis"},{"key":"9611_CR16","unstructured":"US Department of Health and Human Services (1990) The health benefits of smoking cessation. US DHHS, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, DHHS Publication no. (DCD) 90-8416"},{"key":"9611_CR17","first-page":"1189","volume-title":"IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, vol 83: tobacco smoke and involuntary smoking","author":"International Agency for Research on Cancer","year":"2004","unstructured":"International Agency for Research on Cancer (2004) IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans, vol 83: tobacco smoke and involuntary smoking. IARC press, Lyon, pp 1189\u20131312"},{"key":"9611_CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","volume":"366","author":"M Garcia-Closas","year":"2005","unstructured":"Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW et al (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649\u2013659","journal-title":"Lancet"},{"key":"9611_CR19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(06)69086-7","volume":"368","author":"CM Dresler","year":"2006","unstructured":"Dresler CM, Leon ME, Straif K, Baan R, Secretan B (2006) Reversal of risk upon quitting smoking. Lancet 368:348\u2013349","journal-title":"Lancet"},{"key":"9611_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.juro.2008.03.045","volume":"180","author":"SA Strope","year":"2008","unstructured":"Strope SA, Montie JE (2008) The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 180:31\u201337","journal-title":"J Urol"},{"key":"9611_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1464-410X.2002.02880.x","volume":"90","author":"P Aveyard","year":"2002","unstructured":"Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF (2002) Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 90:228\u2013239","journal-title":"BJU Int"},{"key":"9611_CR22","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.juro.2006.07.147","volume":"176","author":"AM Nieder","year":"2006","unstructured":"Nieder AM, John S, Messina CR, Granek IA, Adler HL (2006) Are patients aware of the association between smoking and bladder cancer? J Urol 176:2405\u20132408","journal-title":"J Urol"},{"key":"9611_CR23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/pmed.1996.0136","volume":"26","author":"RA Breslow","year":"1997","unstructured":"Breslow RA, Sorkin JD, Frey CM, Kessler LG (1997) Americans\u2019 knowledge of cancer risk and survival. Prev Med 26:170\u2013177","journal-title":"Prev Med"},{"key":"9611_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1464-410X.2007.06873.x","volume":"100","author":"C-H Chen","year":"2007","unstructured":"Chen C-H, Shun C-T, Huang K-H et al (2007) Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 100:281\u2013286","journal-title":"BJU Int"},{"key":"9611_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1308\/147870805X28109","volume":"87","author":"J Dearing","year":"2005","unstructured":"Dearing J (2005) Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl 87:85\u201387","journal-title":"Ann R Coll Surg Engl"},{"key":"9611_CR26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1360-0443.2005.01221.x","volume":"100","author":"F Vogt","year":"2005","unstructured":"Vogt F, Hall S, Marteau TM (2005) General practitioners\u2019 and family physicians\u2019 negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction 100:1423\u20131431","journal-title":"Addiction"},{"key":"9611_CR27","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/j.1475-6773.2006.00592.x","volume":"41","author":"Y Bao","year":"2006","unstructured":"Bao Y, Duan N, Fox SA (2006) Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res 41:2114\u20132135","journal-title":"Health Serv Res"},{"key":"9611_CR28","first-page":"CD001292","volume":"2","author":"T Lancaster","year":"2005","unstructured":"Lancaster T, Stead LF (2005) Individual behavioural counseling for smoking cessation. Cochrane Database Syst Rev 2:CD001292","journal-title":"Cochrane Database Syst Rev"},{"key":"9611_CR29","first-page":"CD001007","volume":"2","author":"LF Stead","year":"2000","unstructured":"Stead LF, Lancaster T (2000) Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2:CD001007","journal-title":"Cochrane Database Syst Rev"},{"key":"9611_CR30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00042307-200309000-00003","volume":"13","author":"MA Moyad","year":"2003","unstructured":"Moyad MA (2003) Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements? Curr Opin Urol 13:363\u2013378","journal-title":"Curr Opin Urol"},{"key":"9611_CR31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042307-200309000-00004","volume":"13","author":"MA Moyad","year":"2003","unstructured":"Moyad MA (2003) Bladder cancer recurrence. Part II: what do I tell my patients about lifestyle changes and dietary supplements? Curr Opin Urol 13:379\u2013383","journal-title":"Curr Opin Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9611-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9611-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T08:55:03Z","timestamp":1633683303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9611-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9611"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9611-4","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,10]]}}}